Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Maria V. Deligiorgi & Dimitrios T. Trafalis. (2022) The continuum of care of anticancer treatment-induced hypothyroidism in patients with solid non-thyroid tumors: time for an intimate collaboration between oncologists and endocrinologists. Expert Review of Clinical Pharmacology 15:5, pages 531-549.
Read now
Read now
Apostolos Koffas & Christos Toumpanakis. (2021) Comparative safety review of the current therapies for gastroenteropancreatic neuroendocrine tumors. Expert Opinion on Drug Safety 20:3, pages 321-334.
Read now
Read now
Cemil Bilir, İbrahim Yıldız, Ahmet Bilici, Mahmut Ucar, Veli Berk, Yaşar Yıldız, Ozan Yazıcı, Gökşen İnanç İmamoğlu, Nuri Karadurmuş, Kezban Nur Pilancı, Erkan Arpacı, Özgür Tanrıverdi, Ebru Karcı, Süleyman Temiz, Erdinc Nayır, Esin Oktay, Pınar Dal, İbrahim Petekkaya, Ceyhun Varım & Hakan Cinemre. (2017) Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study. Cancer Investigation 35:4, pages 248-255.
Read now
Read now
José-Manuel Gómez-Sáez. (2016) Sunitinib for the treatment of thyroid cancer. Expert Opinion on Investigational Drugs 25:11, pages 1345-1352.
Read now
Read now
Omar Abdel-Rahman & Mona Fouad. (2014) Risk of thyroid dysfunction in patients with solid tumors treated with VEGF receptor tyrosine kinase inhibitors: a critical literature review and meta analysis. Expert Review of Anticancer Therapy 14:9, pages 1063-1073.
Read now
Read now
Poupak Fallahi, Silvia M Ferrari, Roberto Vita, Andrea Di Domenicantonio, Alda Corrado, Salvatore Benvenga & Alessandro Antonelli. (2014) Thyroid dysfunctions induced by tyrosine kinase inhibitors. Expert Opinion on Drug Safety 13:6, pages 723-733.
Read now
Read now
Articles from other publishers (20)
Jonathan Poirier, Sophie Godemel, Aurélie Mourot, Solange Grunenwald, Harold J Olney, Xuan Kim Le, André Lacroix, Philippe Caron & Isabelle Bourdeau. (2023) Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer Patients: Prevalence and Timeline. The Journal of Clinical Endocrinology & Metabolism 108:9, pages 2336-2342.
Crossref
Crossref
Simone De Leo, Matteo Trevisan, Claudia Moneta & Carla Colombo. (2023) Endocrine-related adverse conditions induced by tyrosine kinase inhibitors. Annales d'Endocrinologie 84:3, pages 374-381.
Crossref
Crossref
Shusuke Uekusa, Maho Nemoto, Yuki Hanai, Misaki Nakashin, Arisu Miyagawa, Sachiko Yanagino, Yoshiki Arita, Takahiro Matsumoto, Kenji Nishizawa, Hidenari Nagai, Koji Higai & Kazuhiro Matsuo. (2023) Risk Factors for Lenvatinib-Induced High-Grade Hypothyroidism in Patients with Hepatocellular Carcinoma: A Retrospective Study. Pharmacology 108:5, pages 460-468.
Crossref
Crossref
Virginia Zamponi & Antongiulio Faggiano. (2022) Ipotiroidismo indotto da sunitinib. L'Endocrinologo 23:4, pages 407-408.
Crossref
Crossref
Anupam Kotwal & Donald S.A. McLeod. (2022) Thyroid Dysfunction from Treatments for Solid Organ Cancers. Endocrinology and Metabolism Clinics of North America 51:2, pages 265-286.
Crossref
Crossref
Alessio Basolo, Antonio Matrone, Rossella Elisei & Ferruccio Santini. (2022) Effects of tyrosine kinase inhibitors on thyroid function and thyroid hormone metabolism. Seminars in Cancer Biology 79, pages 197-202.
Crossref
Crossref
Miyuki Harada, Fuminori Kimura, Yasushi Takai, Takeshi Nakajima, Kimio Ushijima, Hiroaki Kobayashi, Toyomi Satoh, Akiko Tozawa, Kohei Sugimoto, Shigehira Saji, Chikako Shimizu, Kyoko Akiyama, Hiroko Bando, Akira Kuwahara, Tatsuro Furui, Hiroshi Okada, Koji Kawai, Nobuo Shinohara, Koichi Nagao, Michio Kitajima, Souichi Suenobu, Toshinori Soejima, Mitsuru Miyachi, Yoko Miyoshi, Akihiro Yoneda, Akihito Horie, Yasushi Ishida, Noriko Usui, Yoshinobu Kanda, Nobuharu Fujii, Makoto Endo, Robert Nakayama, Manabu Hoshi, Tsukasa Yonemoto, Chikako Kiyotani, Natsuko Okita, Eishi Baba, Manabu Muto, Iwaho Kikuchi, Ken-ichirou Morishige, Koichiro Tsugawa, Hiroyuki Nishiyama, Hajime Hosoi, Mitsune Tanimoto, Akira Kawai, Kazuhiko Sugiyama, Narikazu Boku, Masato Yonemura, Naoko Hayashi, Daisuke Aoki, Yutaka Osuga & Nao Suzuki. (2022) Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1. International Journal of Clinical Oncology 27:2, pages 265-280.
Crossref
Crossref
Maria V. Deligiorgi & Dimitrios T. Trafalis. (2021) The Intriguing Thyroid Hormones–Lung Cancer Association as Exemplification of the Thyroid Hormones–Cancer Association: Three Decades of Evolving Research. International Journal of Molecular Sciences 23:1, pages 436.
Crossref
Crossref
Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, Alessia Mennitto, Carlo Messina, Chiara Airoldi, Gianmarco Vannini & Melissa Bersanelli. (2021) Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?. Therapeutic Advances in Urology 13, pages 175628722110297.
Crossref
Crossref
G. Roviello, D. Villari & R. Roudi. (2020) Immunotherapy‑based combinations versus standard first‑line and hypothyroidism risk. Clinical and Translational Oncology 22:9, pages 1664-1665.
Crossref
Crossref
Saptarshi Bhattacharya, Alpesh Goyal, Parjeet Kaur, Randeep Singh & Sanjay Kalra. (2020) Anticancer Drug-induced Thyroid Dysfunction. European Endocrinology 16:1, pages 32.
Crossref
Crossref
Arnaud Jannin, Nicolas Penel, Miriam Ladsous, Marie Christine Vantyghem & Christine Do Cao. (2019) Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders. Critical Reviews in Oncology/Hematology 141, pages 23-35.
Crossref
Crossref
Delphine Drui, Frédéric Illouz, Christine Do Cao & Philippe Caron. (2018) Expert opinion on thyroid complications of new anti-cancer therapies: Tyrosine kinase inhibitors. Annales d'Endocrinologie 79:5, pages 569-573.
Crossref
Crossref
Roberto Iacovelli, Elena Verri, Maria Cossu Rocca, Gaetano Aurilio, Daniela Cullurà, Ottavio de Cobelli & Franco Nolè. (2017) Prognostic role of the cumulative toxicity in patients affected by metastatic renal cells carcinoma and treated with first-line tyrosine kinase inhibitors. Anti-Cancer Drugs 28:2, pages 206-212.
Crossref
Crossref
Marianne Pavel, Juan W. Valle, Barbro Eriksson, Anja Rinke, Martyn Caplin, Jie Chen, Frederico Costa, Jenny Falkerby, Nicola Fazio, Vera Gorbounova, Wouter de Herder, Matthew Kulke, Catherine Lombard-Bohas, Juan O'Connor, Halfdan Sorbye & Rocio Garcia-Carbonero. (2017) ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. Neuroendocrinology 105:3, pages 266-280.
Crossref
Crossref
Helen Gharwan & Hunter Groninger. (2015) Kinase inhibitors and monoclonal antibodies in oncology: clinical implications. Nature Reviews Clinical Oncology 13:4, pages 209-227.
Crossref
Crossref
S. de Groot, L. G. M. Janssen, A. Charehbili, E. M. Dijkgraaf, V. T. H. B. M. Smit, L. W. Kessels, A. van Bochove, H. W. M. van Laarhoven, E. Meershoek-Klein Kranenbarg, A. E. van Leeuwen-Stok, C. J. H. van de Velde, H. Putter, J. W. R. Nortier, J. J. M. van der Hoeven, H. Pijl & J. R. Kroep. (2015) Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01). Breast Cancer Research and Treatment 149:2, pages 461-466.
Crossref
Crossref
Juan W. Valle, Sandrine Faivre, Richard A. Hubner, Enrique Grande & Eric Raymond. (2014) Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumors. Cancer Treatment Reviews 40:10, pages 1230-1238.
Crossref
Crossref
Yihai Cao. (2014) VEGF-targeted cancer therapeutics—paradoxical effects in endocrine organs. Nature Reviews Endocrinology 10:9, pages 530-539.
Crossref
Crossref
Hala Ahmadieh & Ibrahim Salti. (2013) Tyrosine Kinase Inhibitors Induced Thyroid Dysfunction: A Review of Its Incidence, Pathophysiology, Clinical Relevance, and Treatment. BioMed Research International 2013, pages 1-9.
Crossref
Crossref